share_log

Cullinan Therapeutics公布了Zipalertinib的关键性2B期Rezilient1研究的积极初步数据

Zhitong Finance ·  Jun 1 07:06

Cullinan Therapeutics公布了Zipalertinib的关键性2B期Rezilient1研究的积极初步数据

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment